版本:
中国

BRIEF-Celsion updates clinical data from the ovation study

May 4 Celsion Corp:

* Celsion updates clinical data from the ovation study in newly diagnosed advanced ovarian cancer patients

* Celsion - of five evaluable patients in first two cohorts who have been on study for over one year, only one patient's cancer progressed after 11.7 months

* Also reported preliminary translational research findings from first four patient cohorts

* Translational research findings demonstrate that GEN-1 in ovarian cancer patients is biologically active Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐